Your browser doesn't support javascript.
loading
Current status of the diagnosis and treatment of chronic hepatitis B virus infection with immune control / 临床肝胆病杂志
Journal of Clinical Hepatology ; (12): 1134-1137, 2020.
Article in Chinese | WPRIM | ID: wpr-822001
ABSTRACT
Patients with chronic hepatitis B virus (HBV) infection with immune control generally have no or little liver damage, with a low incidence rate of adverse events, and spontaneous HBsAg seroclearance may occur in some patients. Most scholars do not recommend antiviral therapy for such patients in China and foreign countries. However, with the gradual aging of chronic HBV infection, patients with immune control are also faced with disease progression and the development of liver cirrhosis or liver cancer. This article introduces the clinical significance of appropriate timing of antiviral therapy for the prognosis of patients with chronic HBV infection with immune control.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Diagnostic study Language: Chinese Journal: Journal of Clinical Hepatology Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Diagnostic study Language: Chinese Journal: Journal of Clinical Hepatology Year: 2020 Type: Article